ID: ALA2261433

Max Phase: Preclinical

Molecular Formula: C16H18N2O4S

Molecular Weight: 334.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)C1=C(C)N=C(SCCC(=O)O)NC1c1cccc(O)c1

Standard InChI:  InChI=1S/C16H18N2O4S/c1-9-14(10(2)19)15(11-4-3-5-12(20)8-11)18-16(17-9)23-7-6-13(21)22/h3-5,8,15,20H,6-7H2,1-2H3,(H,17,18)(H,21,22)

Standard InChI Key:  LFVCHCWJLBIVBU-UHFFFAOYSA-N

Associated Targets(Human)

Dihydrofolate reductase 3072 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bifunctional dihydrofolate reductase-thymidylate synthase 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Toxoplasma gondii 4585 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 334.40Molecular Weight (Monoisotopic): 334.0987AlogP: 2.46#Rotatable Bonds: 5
Polar Surface Area: 98.99Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.62CX Basic pKa: 6.20CX LogP: 0.34CX LogD: -0.78
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.76Np Likeness Score: -0.46

References

1. Saudi MNS, Gaafar MR, El-Azzouni MZ, Ibrahim MA, Eissa MM.  (2008)  Synthesis and evaluation of some pyrimidine analogs against toxoplasmosis,  17  (9): [10.1007/s00044-008-9097-0]

Source